Gene and Mirna Regulatory Networks During Different Stages of Crohn’s Disease
Sare Verstockt(KU Leuven), Isabelle Cleynen(Universidad Carlos III de Madrid), Kathleen Machiels(KU Leuven), Séverine Vermeire(KU Leuven), Marc Ferrante(Universitair Ziekenhuis Leuven), Bram Verstockt(Universitair Ziekenhuis Leuven), Maaike Vancamelbeke(KU Leuven), Gert Van Assche(KU Leuven), Jan Van der Goten(KU Leuven), Frans Schuit(KU Leuven), Leentje Van Lommel(KU Leuven), Gert De Hertogh(KU Leuven), Paul Rutgeerts(KU Leuven), Ingrid Arijs(BirdLife International)
Cited by 49
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k